Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant protein consisting of modified human growth hormone releasing hormone and the translocation and endopeptidase domains of botulinum toxin serotype D

EU orphan designation number: EU/3/11/947   
Active ingredient: Recombinant protein consisting of modified human growth hormone releasing hormone and the translocation and endopeptidase domains of botulinum toxin serotype D
Indication: Treatment of acromegaly
Sponsor: Syntaxin Limited
Units 4-10 The Quadrant, Barton Lane, Abingdon OX14 3YS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/01/2012 Centralised Orphan - Designation EMA/OD/108/11 (2012)133 of 11/01/2012